Subscribe to RSS - Option Care

Option Care

Short take: Option Care


Bannockburn, Ill.-based Option Care has been chosen by Paratek Pharmaceuticals as a limited network provider of its new IV and oral antibiotic Nuzyra, to treat adults with community-acquired pneumonia and acute bacterial skin infections.

Option Care debuts in Louisiana


NEW ORLEANS – Option Care has opened its first care management center in Louisiana, the home infusion provider announced Aug. 7. The center opened June 11 in Elmwood.

Elite certification ‘validates’ Option Care nurses


Option Care recently recognized 19 of its nurses for passing the Certified Registered Nurse Infusion (CRNI) examination this spring.

In brief: CMS releases adjusted rates, ResMed buys another software provider


WASHINGTON – CMS on May 25 published the adjusted reimbursement rates that will go into effect for seven months in rural areas.

Option Care nurses receive infusion certification


BANNOCKBURN, Ill. – Option Care, a provider of home and alternate treatment site infusion therapy services, recognizes 19 of its nurses for passing the Certified Registered Nurse Infusion (CRNI) examination this spring.

In brief: Lincare settles, DME MAC highlights top errors


CLEARWATER, Fla. – Lincare will pay $875,000 to settle a lawsuit filed by employees whose information may have been exposed in a “phishing attack.”

Study: Home infusion therapy can improve survival rates


BANNOCKBURN, Ill. – Inotropic home infusion therapy can help improve survival for patients with advanced heart failure, according to a new study from Option Care and the Keck School of Medicine of USC.

In brief: NSM enters Pine Tree State, Cure Medical expands


NASHVILLE, Tenn. – National Seating & Mobility has opened a branch in Bangor, Maine—its first in the state, it announced last week. The provider also plans to open a branch in Portland this spring.

Option Care tapped to provide new HIV therapy


BANNOCKBURN, Ill. – Option Care has been selected by Theratechnologies as an infusion provider for Trogarzo, multidrug resistant human immunodeficiency virus type 1 (HIV-1) infections.

Option Care’s new CEO: Home infusion at ‘interesting intersection’


BANNOCKBURN, Ill. – Option Care kicked off the new year with a new CEO, John Rademacher, who had previously served as interim CEO and COO.